The first round of Missouri Blue Shield designations has been released, with Callaway County being absent.

Bengaluru: AstraZeneca is reportedly in discussions with Summit Therapeutics to license an experimental lung cancer drug in a ...

Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...

Pittsburgh’s best MSP earns Top 100 spot for second year, recognized for cybersecurity and CMMC compliance leadership in 2025 MSP 501 rankings. Ranking in the Top 100 again shows how our cybersecurity ...

ASTRAZENECA is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal worth as much as $15 billion, Bloomberg News reported on Thursday, citing people familiar with ...

UK pharma major AstraZeneca is in talks with Summit Therapeutics to license an experimental lung-cancer drug under a deal ...

Summit Therapeutics nears a $15B AstraZeneca deal for ivonescimab, targeting a $90B market. See more on the potential and ...

From moisturisers to serums, skincare is a subsector that keeps drawing in private equity investment.

A cautious market traded AstraZeneca stock down by more than 2% following the report, on a day when the S&P 500 index landed ...

A large, well-capitalized peer is apparently interested in a partnership deal with the company. The media outlet in question ...

Shares in Summit Therapeutics have risen sharply on a report that AstraZeneca is in discussions for a partnership focused on ...